Table:
begin	end	state
1	16	cytoplasmic
17	38	transmembrane
39	57	non-cytoplasmic
58	77	transmembrane
78	85	cytoplasmic
86	105	transmembrane
106	110	non-cytoplasmic
111	133	transmembrane
134	143	cytoplasmic
144	162	transmembrane
163	173	non-cytoplasmic
174	193	transmembrane
194	253	cytoplasmic
254	276	transmembrane
277	289	non-cytoplasmic
290	312	transmembrane
313	319	cytoplasmic
320	341	transmembrane
342	352	non-cytoplasmic
353	374	transmembrane
375	386	cytoplasmic
387	412	transmembrane
413	418	non-cytoplasmic
419	437	transmembrane
438	463	cytoplasmic

Input:
>N515DRAFT_1228
MNSQAIATPTAHVKGTVIYTCVLAALAGLMFGLDIGVISGASQFIKAEFAISDHTIEWIV
SSMMFGAAVGALGAGWLSSHLGRKRSLILGAILFVIGSLLCGLAWSPETLIAARVILGLA
IGIATFTAPLYLAEVAPEHIRGAMISTYQLMITIGILVAFLSDTALSYHGAWRWMLGVIA
IPGALFLLGVLGLPDSPRWLMMRGRRDEAIDVLRRLRGDEVVVAREAADIEEQLKTPQRG
WDLFAENPNFRRSVFLGALLQIMQQFTGMNVVMYYAPRIFQEMGYDTAAQMWFTALVGLT
NVLATFIAIALIDRWGRKPILYTGFAVMAVGLGVVGALMNGGINGQTEQYTCVAMLLFFI
VGFAMSAGPLVWTLCSEIQPLKGRDFGIGVSTFTNWITNMVVGFTFLSLLNTIGNASTFW
LYAALNAVFIVLTFWLVPETKGVTLEQIERNLMAGKRLRDIGR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server